Lunai Bioworks Inc. (LNAI)
NASDAQ: LNAI · Real-Time Price · USD
0.7804
-0.0597 (-7.11%)
At close: Jan 30, 2026, 4:00 PM EST
0.7756
-0.0048 (-0.62%)
After-hours: Jan 30, 2026, 7:29 PM EST
Lunai Bioworks Employees
Lunai Bioworks had 29 employees as of June 30, 2025. The number of employees increased by 4 or 16.00% compared to the previous year.
Employees
29
Change (1Y)
4
Growth (1Y)
16.00%
Revenue / Employee
n/a
Profits / Employee
-$4,516,429
Market Cap
18.29M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 29 | 4 | 16.00% |
| Jun 30, 2024 | 25 | 13 | 108.33% |
| Jun 30, 2023 | 12 | -10 | -45.45% |
| Jun 30, 2022 | 22 | 11 | 100.00% |
| Jun 30, 2021 | 11 | 1 | 10.00% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 61 |
| Citius Pharmaceuticals | 23 |
| IN8bio | 17 |
| Quantum BioPharma | 17 |
| VYNE Therapeutics | 13 |
| Iterum Therapeutics | 9 |
| Lexaria Bioscience | 7 |
| Allarity Therapeutics | 7 |
LNAI News
- 3 days ago - Lunai Bioworks (NASDAQ: LNAI) Launches Sentinel, an AI Safeguard to Block Large Language Models from Generating Novel Chemical Weapons - PRNewsWire
- 4 days ago - Lunai Bioworks (NASDAQ: LNAI) Expands NIH-Funded AI Program into Commercial Alcohol Use Disorder Drug Discovery - PRNewsWire
- 6 weeks ago - Lunai Bioworks (NASDAQ: LNAI) Featured in International Business Times as AI Partnership Talks Advance - PRNewsWire
- 7 weeks ago - Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market - PRNewsWire
- 2 months ago - Lunai Bioworks Secures First Licensing LOI Following Landmark Breakthrough Showing Complete Tumor Regression in Humanized Cancer Models - PRNewsWire
- 3 months ago - Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy - PRNewsWire
- 3 months ago - Lunai Bioworks Harnesses AI and Zebrafish Data to Advance Early Detection of Neurotoxic Compounds - Accesswire
- 3 months ago - Landmark Study Identifies Prognostic Biomarkers in Duchenne Muscular Dystrophy Using Large-Scale Serum Proteomics - Accesswire